Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
Year: 2005
Type: review
Source: Annals of Pharmacotherapy
DOI: 10.1345/aph.1e572
Institutions: Duke University, Duke Medical Center, Duke University Hospital
Language: English
Topic: Aldose Reductase and Taurine
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2103761135